← Back to Company DatabaseVisit Website
Syapse
Precision medicine real-world evidence platform for oncology.
Series C+San Francisco, CAFounded 2008
About
Syapse provides a real-world evidence platform that helps health systems deliver precision oncology care and generate insights from clinical data. The platform integrates genomic, clinical, and outcomes data to support treatment decisions and research. Syapse partners with leading health systems and life sciences companies to improve cancer care delivery.
Total Funding
$100MKey Product
Syapse Learning Health Network platformGeography
North AmericaKey Investors
Pfizer VenturesAscension VenturesSafeguard Scientifics
Focus Areas
Data / AnalyticsTreatment (Therapeutics)
Technology
Digital Health / SoftwareAI / Machine Learning
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026